Is AbbVie Stock a Buy?
With its shares offering a total return of nearly 49% over the last three years, trumping the market's return of 33%, AbbVie (NYSE: ABBV) is a powerhouse big pharma that has a lot of upside to offer to investors.
While there's no guarantee the next three years of the company's life will outperform the market, there's a solid thesis for why it's not improbable. Here's what you need to know about this stock to decide whether you want to own it.
AbbVie is notable among the major pharma businesses for its smooth execution of its carefully planned pipeline strategy. Assuming that reputation holds up, it's a significant reason to think about buying the stock.
Source Fool.com
AbbVie Inc. Aktie
215,60 €
-0,69 %
Mit 45 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung ist AbbVie Inc. einer der Lieblinge unserere Community.
Das von der Community festgelegte Kursziel von 230 € für AbbVie Inc. deutet auf ein leichtes Wachstumspotenzial im Vergleich zu 215.6 € hin.
